Table 1.
Patient characteristics in prior MI and control groups
| Clinical variable | Prior MI (n = 40) | Controls (n = 40) | p value |
|---|---|---|---|
| Age | 60 ± 11 | 57 ± 10 | 0.29 |
| Females | 9/40 (23%) | 9/40 (23%) | – |
| LVEF (%) | 62.3 ± 3.9 | 62.1 ± 3.8 | 0.82 |
| LV mass (g) | 107.9 ± 24.6 | 100.7 ± 23.8 | 0.18 |
| LVEDV (ml) | 159.8 ± 34.3 | 161.3 ± 30.2 | 0.84 |
| Systolic blood pressure (mmHg) | 133 ± 25.6 | 130.0 ± 12.3 | 0.61 |
| Diastolic blood pressure (mmHg) | 78 ± 19.5 | 73.0 ± 9.8 | 0.19 |
| Body mass index (kg/m2) | 27.9 ± 3.4 | 27.8 ± 3.9 | 0.82 |
| Hemoglobin (g/L) | 146 ± 11.5 | 142 ± 14.5 | 0.27 |
| Creatinine (micromol/L) | 77 ± 13.4 | 75 ± 13.6 | 0.52 |
| Estimated GFR (ml/min/1.73 m2) | 81 ± 8.5 | 83 ± 9.1 | 0.83 |
| Hypertension | 13/40 (33%) | 4/40 (9%) | 0.008 |
| Hypercholesterolemia | 10/40 (25%) | 1/40 (3%) | 0.004 |
| Diabetes mellitus | 6/40 (15%) | 0/40 | 0.02 |
| Smoking | 18/40 (45%) | 2/40 (6%) | <0.001 |